FLDM
$3.35
Fluidigm
($.22)
(6.16%)
FLDM
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.14)
Revenue:  $29.22 Mil
Monday
May 11
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when FLDM reports earnings?
Beat
Meet
Miss

Where is FLDM's stock price going from here?
Up
Flat
Down
Stock chart of FLDM
Analysts
Summary of analysts' recommendations for FLDM
Score
Grade
Pivots
Resistance
$3.92
$3.78
$3.57

$3.43

Support
$3.22
$3.08
$2.87
Tweet
Growth
Description
Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California.
Peers
IlluminaAgilent TechnologiesPerkinElmerCoherentTranslate BioBio-Rad LaboratoriesHarvard Bioscience